{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:36:36Z","timestamp":1783528596622,"version":"3.55.0"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["ZIAAI00125101"],"award-info":[{"award-number":["ZIAAI00125101"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.588776","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T12:18:18Z","timestamp":1602073098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["T Cells in Autoimmunity-Associated Cardiovascular Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Daniella Muallem","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarohan M.","family":"Burma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses M.","family":"Kitakule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000725","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001347","article-title":"Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice","volume":"127","author":"Kyaw","year":"2013","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.24.2919","article-title":"Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice","volume":"102","author":"Zhou","year":"2000","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.081","article-title":"Taming Immune and Inflammatory Responses to Treat Atherosclerosis","volume":"71","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/JLB.1MIR0420-076R","article-title":"Functional crosstalk between T cells and monocytes in cancer and atherosclerosis","volume":"108","author":"Padgett","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00387","article-title":"Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity","volume":"7","author":"Yin","year":"2016","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78086","article-title":"Genetic basis of autoimmunity","volume":"125","author":"Marson","year":"2015","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78089","article-title":"T cells in the control of organ-specific autoimmunity","volume":"125","author":"Bluestone","year":"2015","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez650","article-title":"Amplified prevalence and incidence of cardiovascular disease in patients with inflammatory arthritis and coexistent autoimmune disorders","volume":"59","author":"Heslinga","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz009","article-title":"Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study","volume":"115","author":"Elnabawi","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks","volume":"139","author":"von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jid.2019.07.679","article-title":"A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jid.2020.01.025","article-title":"A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001670","article-title":"Persistent expansion of CD4+ effector memory T cells in Wegener\u2019s granulomatosis","volume":"70","author":"Abdulahad","year":"2006","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6984563","DOI":"10.1155\/2018\/6984563","article-title":"Phenotypic Characterization of Circulating CD4(+) T Cells in ANCA-Associated Vasculitis","volume":"2018","author":"Lilliebladh","year":"2018","journal-title":"J Immunol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/art.24747","article-title":"Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Abdulahad","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.22757","article-title":"Expression of the chemokine RANTES in pulmonary Wegener\u2019s granulomatosis","volume":"32","author":"Coulomb-L\u2019Hermine","year":"2001","journal-title":"Hum Pathol"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V12122636","article-title":"Human glomerulonephritis accompanied by active cellular infiltrates shows effector T cells in urine","volume":"12","author":"Sakatsume","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.30355","article-title":"Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener\u2019s)","volume":"63","author":"de Menthon","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.12.004","article-title":"Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener\u2019s granulomatosis","volume":"127","author":"Capraru","year":"2008","journal-title":"Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075058","article-title":"Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity","volume":"30","author":"Kanno","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH656>3.0.CO;2-M","article-title":"Localized Wegener\u2019s granulomatosis: predominance of CD26 and IFN-gamma expression","volume":"192","author":"Muller","year":"2000","journal-title":"J Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1521-6616(03)00121-9","article-title":"Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener\u2019s granulomatosis","volume":"108","author":"Lamprecht","year":"2003","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-267542","article-title":"Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome","volume":"116","author":"Terrier","year":"2010","journal-title":"Blood"},{"key":"B35","article-title":"Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome","volume":"29","author":"Jakiela","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket406","article-title":"Circulating T follicular helper cell and regulatory T cell frequencies are influenced by B cell depletion in patients with granulomatosis with polyangiitis","volume":"53","author":"Zhao","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/ar4247","article-title":"Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA)","volume":"15","author":"Abdulahad","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78182","article-title":"Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis","volume":"125","author":"Millet","year":"2015","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/art.30366","article-title":"CD4+CD28- T cell expansion in granulomatosis with polyangiitis (Wegener\u2019s) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality","volume":"63","author":"Morgan","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy493","article-title":"Subclinical Reactivation of Cytomegalovirus Drives CD4+CD28null T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"219","author":"Chanouzas","year":"2019","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/S0140-6736(15)60345-2","article-title":"CD4+CD28- T-cell expansions in ANCA-associated vasculitis and association with arterial stiffness: baseline data from a randomised controlled trial","volume":"385","author":"Chanouzas","year":"2015","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000118476.29352.2A","article-title":"Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes","volume":"109","author":"Zal","year":"2004","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3643-8","article-title":"CD4(+)CD28(null) T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis","volume":"37","author":"Slot","year":"2017","journal-title":"Rheumatol Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg cells in autoimmunity: from identification to Treg-based therapies","volume":"41","author":"Goschl","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646810","article-title":"Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis","volume":"47","author":"Szczeklik","year":"2017","journal-title":"Eur J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.37959","article-title":"Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.10.005","article-title":"Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis","volume":"71","author":"Rani","year":"2015","journal-title":"Cytokine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e18734","DOI":"10.1371\/journal.pone.0018734","article-title":"Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Rimbert","year":"2011","journal-title":"PLoS One"},{"key":"B50","first-page":"72","article-title":"Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener\u2019s granulomatosis","volume":"28","author":"Klapa","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq328","article-title":"FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells","volume":"50","author":"Abdulahad","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1681\/ASN.2015121356","article-title":"CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN","volume":"28","author":"Chang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jaut.2016.12.004","article-title":"Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis","volume":"78","author":"Kerstein","year":"2017","journal-title":"J Autoimmun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1RU0814-382","article-title":"CD4+\/CD8+ double-positive T cells: more than just a developmental stage","volume":"97","author":"Overgaard","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1991.tb01294.x","article-title":"Temporal artery morphology and morphometry in giant cell arteritis","volume":"99","author":"Nordborg","year":"1991","journal-title":"APMIS"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.07.005","article-title":"Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis","volume":"84","author":"Watanabe","year":"2017","journal-title":"Joint Bone Spine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.05.002","article-title":"Pathogenesis of giant cell arteritis: More than just an inflammatory condition","volume":"9","author":"Ly","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1568-9972(03)00064-8","article-title":"Immunopathways in giant cell arteritis and polymyalgia rheumatica","volume":"3","author":"Weyand","year":"2004","journal-title":"Autoimmun Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32833ee946","article-title":"IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis","volume":"23","author":"Weyand","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/art.34647","article-title":"Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65175-9","article-title":"Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells","volume":"155","author":"Kaiser","year":"1999","journal-title":"Am J Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6","article-title":"Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis","volume":"41","author":"Kaiser","year":"1998","journal-title":"Arthritis Rheum"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.1653454","article-title":"Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF","volume":"253","author":"Ferns","year":"1991","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1093\/rheumatology\/kex424","article-title":"Large-vessel giant cell arteritis: diagnosis, monitoring and management","volume":"57","author":"Koster","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/art.34327","article-title":"Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis","volume":"64","author":"Terrier","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B68","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/art.37865","article-title":"Functionally relevant treg cells are present in giant cell arteritis lesions: comment on the article by Samson et al","volume":"65","author":"Corbera-Bellalta","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/art.37863","article-title":"Reply: To PMID 22833233","volume":"65","author":"Samson","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201836","article-title":"Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis","volume":"72","author":"Espigol-Frigole","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12920-018-0376-4","article-title":"Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis","volume":"11","author":"De Smit","year":"2018","journal-title":"BMC Med Genomics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2016.05.008","article-title":"Involvement and prognosis value of CD8(+) T cells in giant cell arteritis","volume":"72","author":"Samson","year":"2016","journal-title":"J Autoimmun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2018.09.001","article-title":"New Insights Into the Biology of CD8 Regulatory T Cells","volume":"140","author":"Nakagawa","year":"2018","journal-title":"Adv Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid Arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann Intern Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/art.21628","article-title":"Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations","volume":"54","author":"Liang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00353","article-title":"Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis","volume":"10","author":"Chemin","year":"2019","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.39419","article-title":"Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis","volume":"68","author":"Winchester","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118638","article-title":"CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity","volume":"97","author":"Schmidt","year":"1996","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00195","article-title":"Expansions of Cytotoxic CD4(+)CD28(-) T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection","volume":"8","author":"Broadley","year":"2017","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000131450.66017.B3","article-title":"CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients","volume":"109","author":"Gerli","year":"2004","journal-title":"Circulation"},{"key":"B86","first-page":"250","article-title":"THU0129\u2005Cd8+cd28- t-lymphocytes are associated with subclinical atherosclerosis in patients with rheumatoid arthritis, Poster Presentations","volume-title":"Ann Rheum Dis","author":"Wahlin","year":"2017"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0456-4","article-title":"Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity","volume":"20","author":"Yoo","year":"2019","journal-title":"Nat Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204250","article-title":"Angiogenic T cells are decreased in rheumatoid arthritis patients","volume":"74","author":"Rodriguez-Carrio","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am Heart J"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","article-title":"Psoriasis and comorbid diseases: Implications for management","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000147","article-title":"Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis","volume":"27","author":"Mease","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2018.10.006","article-title":"Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis","volume":"29","author":"Huang","year":"2019","journal-title":"Cell Metab"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.021","article-title":"Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A","volume":"138","author":"Li","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.021","article-title":"Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis","volume":"139","author":"Schuler","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.2589","article-title":"Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index","volume":"4","author":"Elnabawi","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/bjd.13993","article-title":"Frequency and characteristics of circulating CD4(+) CD28(null) T cells in patients with psoriasis","volume":"173","author":"Lima","year":"2015","journal-title":"Br J Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.1996.d01-182.x","article-title":"Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin","volume":"21","author":"De Rie","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12812","article-title":"Interferon-gamma\/CCR5 expression in invariant natural killer T cells and CCL5 expression in capillary veins of dermal papillae correlate with development of psoriasis vulgaris","volume":"170","author":"Kono","year":"2014","journal-title":"Br J Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01393","article-title":"Invariant Natural Killer T Cell Subsets-More Than Just Developmental Intermediates","volume":"9","author":"Krovi","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92217","article-title":"CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice","volume":"127","author":"Bagchi","year":"2017","journal-title":"J Clin Invest"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)30546-x","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"D\u00f6rner","year":"2019","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/art.40737","article-title":"Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus","volume":"71","author":"Dall\u2019Era","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.4.2354","article-title":"The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus","volume":"167","author":"Lawson","year":"2001","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203759","article-title":"Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-\/- mice","volume":"74","author":"Wilhelm","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602311103","article-title":"Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus","volume":"103","author":"Stanic","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/art.39818","article-title":"Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction","volume":"69","author":"Furumoto","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200071","article-title":"Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-\/-) mice","volume":"71","author":"van Leuven","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2015.07.001","article-title":"CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus","volume":"63","author":"Clement","year":"2015","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.302680","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on beta2GPI-specific T cell response","volume":"34","author":"Conti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2237-z","article-title":"Th17\/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE)","volume":"32","author":"Zhu","year":"2013","journal-title":"Clin Rheumatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu431","article-title":"Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon alpha on lupus endothelial cell progenitors","volume":"54","author":"Cates","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0102-6","article-title":"Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27","volume":"19","author":"Ryu","year":"2018","journal-title":"Nat Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320917749","article-title":"CD4(+)CD28(null) T cells are expanded in moderately active systemic lupus erythematosus and secrete pro-inflammatory interferon gamma, depending on the Disease Activity Index","volume":"29","author":"Kosmaczewska","year":"2020","journal-title":"Lupus"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2842143","DOI":"10.1155\/2016\/2842143","article-title":"Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus","volume":"2016","author":"Miao","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah4081","article-title":"Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque","volume":"1","author":"Smith","year":"2016","journal-title":"Sci Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J Clin Invest"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/s41598-018-19580-y","article-title":"Increased risk of coronary heart disease among patients with primary Sjogren\u2019s syndrome: a nationwide population-based cohort study","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01234","article-title":"Potential Immunological Links Between Psoriasis and Cardiovascular Disease","volume":"9","author":"Sajja","year":"2018","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311411347","article-title":"Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients","volume":"20","author":"Sazliyana","year":"2011","journal-title":"Lupus"},{"key":"B130","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/14397595.2013.852838","article-title":"Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A","volume":"24","author":"Oryoji","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"42191","DOI":"10.1038\/srep42191","article-title":"Chloroquine inhibits human CD4(+) T-cell activation by AP-1 signaling modulation","volume":"7","author":"Schmidt","year":"2017","journal-title":"Sci Rep"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.22","article-title":"Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases","volume":"13","author":"Croft","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/art.21353","article-title":"Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis","volume":"52","author":"Bryl","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207870","article-title":"Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis","volume":"75","author":"Zhang","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0735-1097(19)32383-6","article-title":"Tocilizumab & Abatacept Were Associated with Lower Risk of Cardiovascular Events Than Rituximab in Rheumatoid Arthritis Patients Failing Tumor Necrosis Factor Inhibitors in a National Study","volume":"73","author":"Hsieh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170926","article-title":"Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease","volume":"45","author":"Jin","year":"2018","journal-title":"J Rheumatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007393","article-title":"Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study","volume":"7","author":"Kang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12056","article-title":"Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept","volume":"16","author":"Gomez-Garcia","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091176","article-title":"Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response","volume":"37","author":"Scarsi","year":"2010","journal-title":"J Rheumatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1154943","article-title":"Abatacept for the treatment of systemic lupus erythematosus","volume":"25","author":"Pimentel-Quiroz","year":"2016","journal-title":"Expert Opin Invest Drugs"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/art.40044","article-title":"Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204164","article-title":"Vasculitis Clinical Research, An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener\u2019s)","volume":"73","author":"Langford","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.01.043","article-title":"Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis","volume":"211","author":"van Leuven","year":"2010","journal-title":"Atherosclerosis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-Dose Methotrexate for the Prevention of Atherosclerotic Events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.588776\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T11:55:52Z","timestamp":1669118152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.588776\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":145,"alternative-id":["10.3389\/fimmu.2020.588776"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.588776","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"article-number":"588776"}}